Completed NA INTERVENTIONAL 2-arm NCT01469585

Oral Contraceptives and Subantimicrobial Doxycycline: Effect on Endometrial Matrix Metalloproteinases

Sponsor: Charles Drew University of Medicine and Science

Interventions Doxycycline

Updated 8 times since 2017 Last updated: Nov 23, 2020 Started: Nov 30, 2011 Primary completion: May 31, 2012 Completion: May 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01469585, this NA trial focuses on Breakthrough Bleeding and remains completed. Sponsored by Charles Drew University of Medicine and Science, it has been updated 8 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2023 — Jul 2024 [monthly]

Completed NA
Dec 2022 — Jan 2023 [monthly]

Completed NA
Jan 2021 — Dec 2022 [monthly]

Completed NA

Status: Unknown Status → Completed

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Unknown Status NA
Feb 2017 — Jun 2018 [monthly]

Unknown Status NA
Jan 2017 — Feb 2017 [monthly]

Unknown Status NA

First recorded

Nov 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Charles Drew University of Medicine and Science
Meharry Medical College
University of Hawaii

Data source: University of Hawaii

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Honolulu, United States